Fuad V. Shammas - Concepedia

Author

Fuad V. Shammas

Stavanger University Hospital

Also Known As

F. V. Shammas, F.V SHAMMAS, FUAD VICTOR SHAMMAS, Fuad Shammas, Fuad V Shammas, Fuad V. Shammas, Fuad Victor Shammas

Publications

497

Citations

H-Index

Concepts

All Affiliations

Stavanger University Hospital United Arab Emirates University University of Stavanger Haukeland University Hospital

About

Fuad V. Shammas is an author at Stavanger University Hospital specializing in medicine, immunology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	216
2	Immunology	5	5	143
3	Health Sciences	3	3	106
4	Cell Biology	3	3	60
5	Engineering	2	2	47

Fuad V. Shammas

Publications

450

Citations

H-Index

Page 1

	Year	Citations
Cisplatin and 5-Fluorouracil in Advanced Cancer of the Penis Fuad V. Shammas, Sigurd Ous, Sophie D. Fosså The Journal of Urology	1992	127
Clinical immunology of chronic cold agglutinin disease Elling Ulvestad, Sigbjørn Berentsen, Kristine Bø, European Journal Of Haematology	1999	88
Chronic cold agglutinin disease of the “idiopathic” type is a premalignant or low‐grade malignant lymphoproliferative disease Sigbjørn Berentsen, Kristine Bø, Fuad V. Shammas, Apmis ImmunohematologyClinical SymptomsImmunodeficienciesImmunologyPathology	1997	66
Fluorescence-based method for measuring and determining the mechanisms of recombination in quantitative PCR Fuad V. Shammas, Reino Heikkilä, Arve Osland Clinica Chimica Acta EngineeringReporter Gene AssayMedicineQuantitative PcrBioanalysis	2001	31
Disseminated Tumor Cells in Bone Marrow Assessed by TWIST1, Cytokeratin 19, and Mammaglobin A mRNA Predict Clinical Outcome in Operable Breast Cancer Patients Kjersti Tjensvoll, Satu Oltedal, Ragne Kristin Farmen, Clinical Breast Cancer Breast OncologyCytokeratin 19MedicinePathologyBone Marrow	2010	23
Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients Ragne Kristin Farmen, Oddmund Nordgård, Bjørnar Gilje, Breast Cancer Research and Treatment Mrna LevelBreast OncologyMedicineIndependent PredictorImmunology	2007	21
Modulation of the systemic inflammatory response by recombinant human interleukin-11: A prospective randomized placebo controlled clinical study in patients with hematological malignancy Michael Ellis, Ulla Hedström, Chris Frampton, Clinical Immunology InflammationCytokineRecombinant Human Interleukin-11Hematological MalignancyMedicine	2006	20
An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy Michael Ellis, Chris Frampton, Jose Joseph, Journal of Medical Microbiology Caspofungin TreatmentImmunologyPathologyClinical MycologyAntimicrobial Chemotherapy	2006	20
Thrombotic Microangiopathy in a Patient with Chronic Myelogenous Leukemia on Hydroxyurea Fuad V. Shammas, Peter Meyer, Reino Heikkilä, Acta Haematologica Chronic PhaseThrombosisHematological MalignancyUrologyOphthalmology	1997	19
Sensitive and quantitative one-step polymerase chain reaction using capillary electrophoresis and fluorescence detection for measuring cytokeratin 19 expression Fuad V. Shammas, M. Van Eekelen, Line Wee, Scandinavian Journal of Clinical and Laboratory Investigation	1999	19

Page 1